Article
Dual targeting of wild-type and mutant p53 by small molecule RITA results in the inhibition of N-Myc and key survival oncogenes and kills neuroblastoma cells in vivo and in vitro.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Sept 2013
Burmakin Mikhail, Shi Yao, Hedström Elisabeth, Kogner Per, Selivanova Galina
Abstract excerpt
PURPOSE: Restoration of the p53 function in tumors is a promising therapeutic strategy due to the high potential of p53 as tumor suppressor and the fact that established tumors depend on p53 inactivation for their survival. Here, we addressed the question whether small molecule RITA can reactivate p53 in neuroblastoma and suppress the growth of neuroblastoma cells in vitro and in vivo. EXPERIMENTAL DESIGN: The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
